Page last updated: 2024-10-26

dipyridamole and B-Cell Chronic Lymphocytic Leukemia

dipyridamole has been researched along with B-Cell Chronic Lymphocytic Leukemia in 2 studies

Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.

Research Excerpts

ExcerptRelevanceReference
"WSU-CLL cells, a fludarabine resistant B-cell chronic lymphocytic leukemia cell line, has been shown to exhibit enhanced sensitivity to 2-chlorodeoxyadenosine (2-CdA) following 48-72 h exposure to bryostatin 1."3.70Bryostatin 1-induced modulation of nucleoside transporters and 2-chlorodeoxyadenosine influx in WSU-CLL cells. ( Ahmad, I; Al-Katib, AM; Beck, FW; Liu, KZ; Mantsch, HH; Mohammad, RM; Wall, NR, 2000)
"Two cases of Toxic Epidermal Necrolysis, with a previous history of drugs intake, and associated to a lymphoma and to a chronic lymphoid leukemia, are presented."1.29[Toxic epidermal necrolysis associated with lymphoproliferative syndromes. Anatomo-clinical study. Presentation of 2 cases]. ( Aguado Santos, A; Gomez Duaso, AJ; Ortiz Reina, S; Sanz Asenjo, A; Seoane Leston, JM, 1993)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Seoane Leston, JM1
Gomez Duaso, AJ1
Sanz Asenjo, A1
Ortiz Reina, S1
Aguado Santos, A1
Beck, FW1
Al-Katib, AM1
Ahmad, I1
Wall, NR1
Liu, KZ1
Mantsch, HH1
Mohammad, RM1

Other Studies

2 other studies available for dipyridamole and B-Cell Chronic Lymphocytic Leukemia

ArticleYear
[Toxic epidermal necrolysis associated with lymphoproliferative syndromes. Anatomo-clinical study. Presentation of 2 cases].
    Revue de stomatologie et de chirurgie maxillo-faciale, 1993, Volume: 94, Issue:5

    Topics: Anesthetics; Dipyridamole; Fatal Outcome; Female; Humans; Insulin; Leukemia, Lymphocytic, Chronic, B

1993
Bryostatin 1-induced modulation of nucleoside transporters and 2-chlorodeoxyadenosine influx in WSU-CLL cells.
    International journal of molecular medicine, 2000, Volume: 5, Issue:4

    Topics: Aged; Antineoplastic Agents; Biological Transport, Active; Bryostatins; Carrier Proteins; Cladribine

2000